Portage Biotech Inc (PRTG) - Market Valuation

Portage Biotech Inc. (PRTG) automates the search for antitumor agents using molecule-screening robots, eliminating laboratory routine. This price chart on GURU.Markets, where the market capitalization stands at 0.01, links the company's technology stack to partnerships focused on developing drugs for tumor environment correction. The business relies on clinical trials to capture a niche amid a shortage of effective treatment methods.

portagebiotech.com - PRTG Market Capitalization (period 07/04/2022 - 09/04/2025)

PRTG (Portage Biotech Corp): analytical breakdowns and indicator data

- market price and analyst price targets:

Price Chart Portage Biotech|PRTG - Fair Value Consensus

- market capitalization indicators:

Market Valuation Portage Biotech Corp|PRTG - Aggregate Business Value

- business book valuation details:

Book Value per Share Portage Biotech|PRTG - Book Value of Business|Market Capitalization to Book Value Ratio portagebiotech.com|PRTG - Company Balance Sheet Assets

- debt obligations and liquidity statistics:

- financial results and valuation multiples details:

PRTG - Net Profit|Expected Profit Portage Biotech Inc.|PRTG - Price to Earnings Ratio|Projected Price to Earnings Portage|PRTG - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Portage Biotech Corp|PRTG - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Portage Biotech|PRTG - Earnings per share for the last 12 months|Quarterly EPS earnings growth portagebiotech.com|PRTG - Net earnings per share growth this year|Net earnings per share growth forecast for next year Portage Biotech Inc.

Fundamental company valuation:Portage Biotech PRTG

Market capitalization determines the current market value of a business, serving as a fundamental indicator of an asset's investment attractiveness. This metric is calculated by multiplying the current share price by the total number of outstanding shares. By analyzing the total value of the issuer's shares, an investor tracks the dynamics of market confidence in the company. For Portage Biotech Inc. (PRTG), this valuation is supported by the potential of iNKT inhibitors. Inelastic demand for unique oncology therapies provides the issuer with significant pricing power during commercialization.

Competitor analysis